Competitiveness as a function of local and regional growth and development

Each economic entity, institution and individual has the responsibility of contributing to the economic development in its region. Creating conditions for the development and empowerment of the business sector are activities that in the long run lead to the strengthening of not only certain economic sectors, but the entire region. In the recent period sources from EU funds for co-financing of capital projects have become available to investors. Given the uncertainty in business conditions, investors’ poor capitalization, lack of business profitability and, in terms of profitability and risk, lack of high-quality capital projects, the benefits of these resources are insufficient and/or inadequately used. The aim of this paper is to analyse the strength and capabilities of Croatian companies for financing and implementation of high-quality capital projects. For this purpose, this paper will present the results of research of financial position of selected companies in 2012. Also, it presents the results of research from 2011 that examined the reality of projections of later activated investment projects. These results are the basis for a conclusion about the ability of management, in the analysed region, to make realistic plans and carry out high-quality capital projects

Patient characteristics.

<p>Patient characteristics.</p

Survival curves in stage IV NSCLC patients according to treatment modality in stage I of T/N category.

<p>Survival curves in stage IV NSCLC patients according to treatment modality in stage I of T/N category.</p

La Charente

23 juillet 18771877/07/23 (A6,N1609)-1877/07/23.Appartient à l’ensemble documentaire : PoitouCh

Patterns of care for stage IV NSCLC patients according to stage of T/N.

<p>Patterns of care for stage IV NSCLC patients according to stage of T/N.</p

Trend of the proportion of stage IV NSCLC patients from 2004 to 2013.

<p>Trend of the proportion of stage IV NSCLC patients from 2004 to 2013.</p

Survival curves in stage IV NSCLC patients according to different treatment modality.

<p>Survival curves in stage IV NSCLC patients according to different treatment modality.</p

Patterns of care for stage IV NSCLC patients according to treatment modality.

<p>Patterns of care for stage IV NSCLC patients according to treatment modality.</p

Wild-type and mutant strains of <i>Fusarium graminearum</i> used in this study.

<p>Wild-type and mutant strains of <i>Fusarium graminearum</i> used in this study.</p

Growth defects of the <i>Fghog1</i>, <i>Fgpbs2</i>, and <i>Fgssk2</i> mutants.

<p><b>A</b>. Colonies of the wild type (PH-1) and the <i>Fghog1</i> (HG15), <i>Fgpbs2</i> (PS15), and <i>Fgssk2</i> (FK13) mutants grown on PDA and 5xYEG agar plates for 3 days. <b>B</b>. Colony surface hydrophobicity tests with the same set of mutants. Photos were taken 15 min. after placing droplets of 50 µl red ink on the surface of the wild-type and mutant colonies. <b>C</b>. Hyphal tip growth and branching patterns of PH-1 and the same set of mutants on PDA plates. The branching angles were reduced in the extension zone of mutant colonies. Bar = 150 µm.</p